212 related articles for article (PubMed ID: 31979093)
61. Valproic acid reprograms the metabolic aberration of cisplatin treatment via ALDH modulation in triple-negative breast cancer cells.
Granit Mizrahi A; Gugenheim A; Hamad H; Hamed R; Tetro N; Maimon O; Khutsurauli S; Nechushtan H; Nisman B; Duran D; Samman W; Birimberg-Schwartz L; Grunewald M; Eyal S; Peretz T
Front Cell Dev Biol; 2023; 11():1217149. PubMed ID: 37954205
[TBL] [Abstract][Full Text] [Related]
62. Breast cancer cells evade paclitaxel-induced cell death by developing resistance to dasatinib.
Jeong YJ; Kang JS; Lee SI; So DM; Yun J; Baek JY; Kim SK; Lee K; Park SK
Oncol Lett; 2016 Sep; 12(3):2153-2158. PubMed ID: 27602155
[TBL] [Abstract][Full Text] [Related]
63. Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells.
Tanei T; Choi DS; Rodriguez AA; Liang DH; Dobrolecki L; Ghosh M; Landis MD; Chang JC
Breast Cancer Res; 2016 Jan; 18(1):6. PubMed ID: 26757880
[TBL] [Abstract][Full Text] [Related]
64. Phenethyl Isothiocyanate Induces Apoptotic Cell Death Through the Mitochondria-dependent Pathway in Gefitinib-resistant NCI-H460 Human Lung Cancer Cells
Hsia TC; Huang YP; Jiang YW; Chen HY; Cheng ZY; Hsiao YT; Chen CY; Peng SF; Chueh FS; Chou YC; Chung JG
Anticancer Res; 2018 Apr; 38(4):2137-2147. PubMed ID: 29599332
[TBL] [Abstract][Full Text] [Related]
65. Targeted Inhibition of miR-221/222 Promotes Cell Sensitivity to Cisplatin in Triple-Negative Breast Cancer MDA-MB-231 Cells.
Li S; Li Q; Lü J; Zhao Q; Li D; Shen L; Wang Z; Liu J; Xie D; Cho WC; Xu S; Yu Z
Front Genet; 2019; 10():1278. PubMed ID: 32010177
[TBL] [Abstract][Full Text] [Related]
66.
Lv X; Pang X; Jin X; Song Y; Li H
Biomed Rep; 2014 Nov; 2(6):910-914. PubMed ID: 25279168
[TBL] [Abstract][Full Text] [Related]
67. Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype.
He Q; Jing H; Liaw L; Gower L; Vary C; Hua S; Yang X
Sci Rep; 2016 Mar; 6():23216. PubMed ID: 26976794
[TBL] [Abstract][Full Text] [Related]
68. High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells.
Varghese S; Samuel SM; Varghese E; Kubatka P; Büsselberg D
Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30626087
[TBL] [Abstract][Full Text] [Related]
69. ERK-modulated intrinsic signaling and G(2)/M phase arrest contribute to the induction of apoptotic death by allyl isothiocyanate in MDA-MB-468 human breast adenocarcinoma cells.
Tsai SC; Huang WW; Huang WC; Lu CC; Chiang JH; Peng SF; Chung JG; Lin YH; Hsu YM; Amagaya S; Yang JS
Int J Oncol; 2012 Dec; 41(6):2065-72. PubMed ID: 23008020
[TBL] [Abstract][Full Text] [Related]
70. Prx2 links ROS homeostasis to stemness of cancer stem cells.
Son YW; Cheon MG; Kim Y; Jang HH
Free Radic Biol Med; 2019 Apr; 134():260-267. PubMed ID: 30611866
[TBL] [Abstract][Full Text] [Related]
71. In vivo β-catenin attenuation by the integrin α5-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis.
Li Y; Xiao Y; Lin HP; Reichel D; Bae Y; Lee EY; Jiang Y; Huang X; Yang C; Wang Z
Biomaterials; 2019 Jan; 188():160-172. PubMed ID: 30352320
[TBL] [Abstract][Full Text] [Related]
72. Chemoresistance in the Human Triple-Negative Breast Cancer Cell Line MDA-MB-231 Induced by Doxorubicin Gradient Is Associated with Epigenetic Alterations in Histone Deacetylase.
Han J; Lim W; You D; Jeong Y; Kim S; Lee JE; Shin TH; Lee G; Park S
J Oncol; 2019; 2019():1345026. PubMed ID: 31275376
[TBL] [Abstract][Full Text] [Related]
73. The Heparan Sulfate Sulfotransferases HS2ST1 and HS3ST2 Are Novel Regulators of Breast Cancer Stem-Cell Properties.
Teixeira FCOB; Vijaya Kumar A; Kumar Katakam S; Cocola C; Pelucchi P; Graf M; Kiesel L; Reinbold R; Pavão MSG; Greve B; Götte M
Front Cell Dev Biol; 2020; 8():559554. PubMed ID: 33102470
[TBL] [Abstract][Full Text] [Related]
74. Phenethyl isothiocyanate and paclitaxel synergistically enhanced apoptosis and alpha-tubulin hyperacetylation in breast cancer cells.
Cang S; Ma Y; Chiao JW; Liu D
Exp Hematol Oncol; 2014 Feb; 3(1):5. PubMed ID: 24495785
[TBL] [Abstract][Full Text] [Related]
75. Novel strategies to target chemoresistant triple-negative breast cancer.
Venkatesh J; Rishi AK; Reddy KB
Genes Cancer; 2020 Dec; 11(3-4):95-105. PubMed ID: 33488948
[TBL] [Abstract][Full Text] [Related]
76. Hypoxia Induces the Acquisition of Cancer Stem-like Phenotype Via Upregulation and Activation of Signal Transducer and Activator of Transcription-3 (STAT3) in MDA-MB-231, a Triple Negative Breast Cancer Cell Line.
Soleymani Abyaneh H; Gupta N; Alshareef A; Gopal K; Lavasanifar A; Lai R
Cancer Microenviron; 2018 Dec; 11(2-3):141-152. PubMed ID: 30255421
[TBL] [Abstract][Full Text] [Related]
77. Small-molecule inhibitors that disrupt the MTDH-SND1 complex suppress breast cancer progression and metastasis.
Shen M; Wei Y; Kim H; Wan L; Jiang YZ; Hang X; Raba M; Remiszewski S; Rowicki M; Wu CG; Wu S; Zhang L; Lu X; Yuan M; Smith HA; Zheng A; Bertino J; Jin JF; Xing Y; Shao ZM; Kang Y
Nat Cancer; 2022 Jan; 3(1):43-59. PubMed ID: 35121987
[TBL] [Abstract][Full Text] [Related]
78. Bioinformatic analysis reveals an association between Metadherin with breast cancer prognosis and tumor immune infiltration.
Yang L; Yang L; Kong F; Zhang S; Pu P; Li X; Song Z
Sci Rep; 2024 Jan; 14(1):1949. PubMed ID: 38253625
[TBL] [Abstract][Full Text] [Related]
79. Tribbles Homolog 3 Involved in Radiation Response of Triple Negative Breast Cancer Cells by Regulating Notch1 Activation.
Lee YC; Wang WL; Chang WC; Huang YH; Hong GC; Wang HL; Chou YH; Tseng HC; Lee HT; Li ST; Chen HL; Wu CC; Yang HF; Wang BY; Chang WW
Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30678233
[TBL] [Abstract][Full Text] [Related]
80. PO-11 - Thrombin and cancer stem-like cells: in vitro support for breast cancer anticoagulation.
Castle J; Farnie G; Kirwan CC
Thromb Res; 2016 Apr; 140 Suppl 1():S180. PubMed ID: 27161699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
